GLOD5
gene geneOn this page
Summary
GLOD5 (glyoxalase domain containing 5, HGNC:33358) is a protein-coding gene on chromosome Xp11.23, encoding Glyoxalase domain-containing protein 5 (A6NK44).
This gene encodes a protein with a glyoxalase domain.
Source: NCBI Gene 392465 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 33 total
- MANE Select transcript:
NM_001080489
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33358 |
| Approved symbol | GLOD5 |
| Name | glyoxalase domain containing 5 |
| Location | Xp11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000171433 |
| Ensembl biotype | protein_coding |
| OMIM | 301112 |
| Entrez | 392465 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000303227, ENST00000445229, ENST00000463327, ENST00000470676
RefSeq mRNA: 1 — MANE Select: NM_001080489
NM_001080489
CCDS: CCDS55410
Canonical transcript exons
ENST00000303227 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001794445 | 48761747 | 48761853 |
| ENSE00001816543 | 48773310 | 48773648 |
| ENSE00003650169 | 48765835 | 48765972 |
| ENSE00003890627 | 48770927 | 48771082 |
Expression profiles
Bgee: expression breadth ubiquitous, 107 present calls, max score 88.22.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0622 / max 18.5137, expressed in 26 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 196284 | 0.0349 | 14 |
| 196283 | 0.0273 | 15 |
Top tissues by expression
219 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.22 | gold quality |
| kidney epithelium | UBERON:0004819 | 85.08 | gold quality |
| ileal mucosa | UBERON:0000331 | 83.86 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 80.88 | gold quality |
| duodenum | UBERON:0002114 | 76.93 | gold quality |
| jejunal mucosa | UBERON:0000399 | 76.72 | gold quality |
| rectum | UBERON:0001052 | 75.87 | gold quality |
| pancreatic ductal cell | CL:0002079 | 75.37 | silver quality |
| buccal mucosa cell | CL:0002336 | 74.73 | gold quality |
| right lobe of liver | UBERON:0001114 | 74.67 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 74.51 | gold quality |
| upper arm skin | UBERON:0004263 | 71.68 | gold quality |
| tibialis anterior | UBERON:0001385 | 70.97 | silver quality |
| right uterine tube | UBERON:0001302 | 68.76 | gold quality |
| liver | UBERON:0002107 | 68.38 | gold quality |
| kidney | UBERON:0002113 | 67.67 | gold quality |
| colonic mucosa | UBERON:0000317 | 67.02 | gold quality |
| small intestine | UBERON:0002108 | 66.88 | gold quality |
| transverse colon | UBERON:0001157 | 66.47 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 66.29 | gold quality |
| islet of Langerhans | UBERON:0000006 | 65.79 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 65.79 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 65.57 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 63.96 | silver quality |
| oviduct epithelium | UBERON:0004804 | 61.80 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 61.54 | gold quality |
| metanephros cortex | UBERON:0010533 | 61.53 | gold quality |
| cortex of kidney | UBERON:0001225 | 61.39 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 61.22 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 61.13 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.54 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
14 targeting GLOD5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-6794-5P | 99.76 | 66.38 | 1048 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-4716-3P | 99.69 | 66.73 | 1022 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-3619-5P | 99.00 | 68.87 | 2308 |
| HSA-MIR-330-5P | 98.73 | 67.63 | 1788 |
| HSA-MIR-214-3P | 98.71 | 68.12 | 2128 |
| HSA-MIR-761 | 98.71 | 68.07 | 2051 |
| HSA-MIR-518C-5P | 98.53 | 69.20 | 1640 |
| HSA-MIR-6764-3P | 98.44 | 67.64 | 1153 |
| HSA-MIR-6824-3P | 98.44 | 67.62 | 1154 |
| HSA-MIR-326 | 98.25 | 66.44 | 1565 |
| HSA-MIR-5704 | 94.82 | 67.46 | 448 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | glod5 | ENSDARG00000071871 |
| mus_musculus | Glod5 | ENSMUSG00000031163 |
| rattus_norvegicus | Glod5 | ENSRNOG00000039571 |
| caenorhabditis_elegans | mce-1 | WBGENE00008415 |
Paralogs (1): MCEE (ENSG00000124370)
Protein
Protein identifiers
Glyoxalase domain-containing protein 5 — A6NK44 (reviewed: A6NK44)
All UniProt accessions (2): A6NK44, H7C348
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the glyoxalase I family.
RefSeq proteins (1): NP_001073958* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004360 | Glyas_Fos-R_dOase_dom | Domain |
| IPR029068 | Glyas_Bleomycin-R_OHBP_Dase | Homologous_superfamily |
| IPR037523 | VOC_core | Domain |
| IPR050383 | GlyoxalaseI/FosfomycinResist | Family |
Pfam: PF00903
UniProt features (13 total): strand 8, helix 2, chain 1, domain 1, turn 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 3ZW5 | X-RAY DIFFRACTION | 1.6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NK44-F1 | 89.67 | 0.78 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 24 (showing top):
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP, chrXp11, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN, ZNF592_TARGET_GENES, MIR586, MIR3619_5P, MIR214_3P, MIR761, MIR330_5P, MIR326, MIR5704, GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN, HAY_BONE_MARROW_CD34_POS_MKP, GSE11818_WT_VS_DICER_KO_TREG_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
444 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GLOD5 | HPDL | Q96IR7 | 582 |
| GLOD5 | TIFAB | Q6ZNK6 | 510 |
| GLOD5 | TMEM231 | Q9H6L2 | 497 |
| GLOD5 | PPFIBP2 | Q8ND30 | 472 |
| GLOD5 | OGFOD1 | Q8N543 | 463 |
| GLOD5 | ITIH5 | Q86UX2 | 461 |
| GLOD5 | MRRF | Q96E11 | 452 |
| GLOD5 | FARSA | Q9Y285 | 435 |
| GLOD5 | MARCHF9 | Q86YJ5 | 426 |
| GLOD5 | GLOD4 | Q9HC38 | 418 |
| GLOD5 | MARCHF2 | Q9P0N8 | 386 |
| GLOD5 | MCEE | Q96PE7 | 366 |
| GLOD5 | HPD | P32754 | 358 |
| GLOD5 | TRMT10B | Q6PF06 | 352 |
| GLOD5 | KLK12 | Q9UKR0 | 334 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HDAC6 | GLOD5 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (1): GLOD5 (Affinity Capture-MS)
ESM2 similar proteins: A0A0U2WCB2, A6NK44, A6QLI6, A8XX92, A9NNH7, B9FK36, O42764, P05165, P07997, P08680, P0DTA4, P13196, P13446, P14882, P16635, P22557, P43090, P54889, Q19842, Q28CR0, Q2KIZ3, Q2QMG2, Q42523, Q42777, Q4KLB0, Q4WHU1, Q502D1, Q553V2, Q5I0C3, Q5R557, Q5R7K1, Q5R9R9, Q612F5, Q63147, Q6CDR5, Q6JQN1, Q759G5, Q872T7, Q8K370, Q91ZA3
Diamond homologs: A0A0U2WCB2, A6NK44, P0C5H0, Q28CR0, Q4KLB0, Q502D1, Q54L71, Q8ZM36, Q9D8I3, Q8CXK5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
33 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
735 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:48763869:A:T | donor_gain | 1.0000 |
| X:48765833:A:AG | acceptor_gain | 1.0000 |
| X:48765834:G:GG | acceptor_gain | 1.0000 |
| X:48770918:A:AG | acceptor_gain | 1.0000 |
| X:48770919:C:G | acceptor_gain | 1.0000 |
| X:48770922:A:G | acceptor_gain | 1.0000 |
| X:48761849:AACAG:A | donor_loss | 0.9900 |
| X:48761851:CAGGT:C | donor_loss | 0.9900 |
| X:48761852:AGGTG:A | donor_loss | 0.9900 |
| X:48761853:GGT:G | donor_loss | 0.9900 |
| X:48761854:GTG:G | donor_loss | 0.9900 |
| X:48761855:T:G | donor_loss | 0.9900 |
| X:48765834:GTC:G | acceptor_gain | 0.9900 |
| X:48765834:GTCAT:G | acceptor_gain | 0.9900 |
| X:48765973:G:GA | donor_loss | 0.9900 |
| X:48765973:G:GG | donor_gain | 0.9900 |
| X:48770907:T:A | acceptor_gain | 0.9900 |
| X:48770921:A:AG | acceptor_gain | 0.9900 |
| X:48770923:G:GG | acceptor_gain | 0.9900 |
| X:48770923:GTA:G | acceptor_gain | 0.9900 |
| X:48763868:G:GT | donor_gain | 0.9800 |
| X:48765972:GGT:G | donor_gain | 0.9800 |
| X:48770926:GGAA:G | acceptor_gain | 0.9800 |
| X:48771081:AGG:A | donor_loss | 0.9800 |
| X:48771082:GGT:G | donor_loss | 0.9800 |
| X:48771083:G:A | donor_loss | 0.9800 |
| X:48771084:T:G | donor_loss | 0.9800 |
| X:48773309:GGCTT:G | acceptor_gain | 0.9800 |
| X:48765973:GTA:G | donor_gain | 0.9700 |
| X:48770926:G:GT | acceptor_gain | 0.9700 |
AlphaMissense
1060 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:48773411:G:C | E153D | 0.987 |
| X:48773411:G:T | E153D | 0.987 |
| X:48771031:C:A | D102E | 0.985 |
| X:48771031:C:G | D102E | 0.985 |
| X:48765931:T:C | F54L | 0.984 |
| X:48765933:T:A | F54L | 0.984 |
| X:48765933:T:G | F54L | 0.984 |
| X:48765891:C:A | H40Q | 0.982 |
| X:48765891:C:G | H40Q | 0.982 |
| X:48771030:A:T | D102V | 0.982 |
| X:48773390:C:A | D146E | 0.981 |
| X:48773390:C:G | D146E | 0.981 |
| X:48765967:T:C | F66L | 0.980 |
| X:48765969:T:A | F66L | 0.980 |
| X:48765969:T:G | F66L | 0.980 |
| X:48770972:C:G | H83D | 0.979 |
| X:48771037:T:G | C104W | 0.979 |
| X:48771035:T:C | C104R | 0.978 |
| X:48773410:A:T | E153V | 0.978 |
| X:48771029:G:C | D102H | 0.977 |
| X:48771030:A:C | D102A | 0.977 |
| X:48773416:C:T | S155F | 0.977 |
| X:48773386:G:C | R145P | 0.975 |
| X:48771036:G:A | C104Y | 0.974 |
| X:48773415:T:C | S155P | 0.974 |
| X:48770970:T:A | L82H | 0.973 |
| X:48773374:C:T | S141F | 0.973 |
| X:48770964:T:C | F80S | 0.971 |
| X:48765888:C:A | D39E | 0.970 |
| X:48765888:C:G | D39E | 0.970 |
dbSNP variants (sampled 300 via entrez): RS1000382999 (X:48772352 A>G), RS1001054983 (X:48766139 T>A,C), RS1001384269 (X:48773799 A>C), RS1002920190 (X:48769787 G>A), RS1003056992 (X:48770353 A>G), RS1003569582 (X:48761224 C>T), RS1003939687 (X:48771924 A>G), RS1004077165 (X:48772266 T>C,G), RS1004101875 (X:48763348 T>A,C), RS1005046582 (X:48764805 A>C), RS1006103498 (X:48767510 C>T), RS1006630909 (X:48760817 C>T), RS1007050047 (X:48768880 A>G), RS1007513433 (X:48769347 A>T), RS1007632084 (X:48762626 A>G)
Disease associations
OMIM: gene MIM:301112 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_91 | Refractive error | 1.000000e-11 |
| GCST90002402_511 | Platelet count | 3.000000e-13 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004309 | platelet count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression, decreases methylation | 2 |
| aminomethylphosphonic acid (AMPA) | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| 2,4-Dichlorophenoxyacetic Acid | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.